Edition:
United States

Michele Gershberg

Special Report: After a child's dire diagnosis, hope and uncertainty at the frontiers of medicine

Dec 06 2018

NEW YORK “I wish I didn’t have this hand anymore,” my 4-year-old son said as he woke one winter morning.

Special Report: Learning about targeted-therapy options

Dec 06 2018

NEW YORK When we were told our son had a potentially life-threatening brain tumor, our family was lucky to have world-class doctors and hospitals close to home and health insurance that covered nearly all his medical expenses and prescription drug costs.

Factbox: Learning about targeted-therapy options

Dec 06 2018

NEW YORK When we were told our son had a potentially life-threatening brain tumour, our family was lucky to have world-class doctors and hospitals close to home and health insurance that covered nearly all his medical expenses and prescription drug costs.

Learning about targeted-therapy options

Dec 06 2018

NEW YORK, Dec 6 When we were told our son had a potentially life-threatening brain tumor, our family was lucky to have world-class doctors and hospitals close to home and health insurance that covered nearly all his medical expenses and prescription drug costs.

After troubled rollout, Obamacare's new test starts on New Year's Day

Dec 29 2013

New Year's Day will bring a fresh test for President Barack Obama's healthcare overhaul, as hundreds of thousands of Americans will begin to use the program's new medical coverage for the first time.

After troubled rollout, Obamacare's new test starts on New Year's Day

Dec 29 2013

New Year's Day will bring a fresh test for President Barack Obama's healthcare overhaul, as hundreds of thousands of Americans will begin to use the program's new medical coverage for the first time.

After troubled rollout, Obamacare's new test starts on New Year's Day

Dec 29 2013

Dec 29 New Year's Day will bring a fresh test for President Barack Obama's healthcare overhaul, as hundreds of thousands of Americans will begin to use the program's new medical coverage for the first time.

Lilly drug slows Alzheimer's in some, fails main goals

Aug 24 2012

NEW YORK/CHICAGO Eli Lilly and Co said its experimental Alzheimer's drug showed signs of slowing mental decline in patients with a mild form of the disease, even though it failed to meet the main goals of two large clinical trials, suggesting the treatment could be salvaged.

Bristol-Myers to buy Amylin for about $5.3 billion

Jun 30 2012

NEW YORK Bristol-Myers Squibb Co will buy biotechnology company Amylin Pharmaceuticals Inc for about $5.3 billion (3.37 billion pounds) in cash, helping Bristol-Myers extend its portfolio of diabetes treatments with the addition of drugs Byetta and Bydureon.

Bristol-Myers to buy Amylin for about $5.3 bln

Jun 30 2012

NEW YORK Bristol-Myers Squibb Co will buy biotechnology company Amylin Pharmaceuticals Inc for about $5.3 billion in cash, helping Bristol-Myers extend its portfolio of diabetes treatments with the addition of drugs Byetta and Bydureon.

World News